Jason Kelly net worth
Quick answer
Jason Kelly's estimated net worth is $75.0M (range $52.5M – $112.5M) as of 2026. Jason Kelly is CEO at Ginkgo Bioworks. Ginkgo Bioworks valuation.
Jason Kelly is CEO at Ginkgo Bioworks (YC S14). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Public
- Education: B.S. in Chemical Engineering and Biology, and Ph.D. in Biological Engineering, all from MIT
- Region: United States of America
- Industries: Healthcare, Industrial Bio
- Team size: 641
- Website: http://ginkgobioworks.com
Who is Jason Kelly?
Jason Kelly is the co-founder and CEO of Ginkgo Bioworks, a synthetic biology company that programs cells for various industries. He has been instrumental in leading the company since its inception in 2008.
Highlights:
- Co-founder and CEO of Ginkgo Bioworks
- Received B.S. degrees in Chemical Engineering and Biology and a Ph.D. in Biologi
- Served as the Chair of the U.S. National Security Commission on Emerging Biotech
About Ginkgo Bioworks
Ginkgo Bioworks is the organism company. We design custom organisms for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.
FAQ: Jason Kelly net worth and Ginkgo Bioworks valuation
What is Jason Kelly's net worth?
Jason Kelly's estimated net worth is $75.0M (range $52.5M – $112.5M) as of 2026. Jason Kelly is CEO at Ginkgo Bioworks. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Ginkgo Bioworks valuation?
Ginkgo Bioworks's estimated valuation on Entrepreneurial Check is $2.0B. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Jason Kelly's role?
Jason Kelly is CEO at Ginkgo Bioworks, a Y Combinator-backed startup (batch S14).